연구동향 분석

Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization

이승규 정지형 최은영* 이성철 고형준 이준행 2015년

논문상세정보
인용/피인용
' Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • choroidalneovascularization
  • hypoxia-induciblefactor-1
  • resveratrol
  • retinal pigment epithelium
  • vascular endothelial growth factor
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,774 0

0.0%

' Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization' 의 참고문헌

  • trans-3,4,5’-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells
    Cao Z Clin Cancer Res 10 : 5253 ~ 5263 [2004]
  • trans-3,4,5’-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells
    Cao Z Clin Cancer Res 10 5253-5263 [2004]
  • Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation
    Minet E Free Radic Biol Med 31 : 847 ~ 855 [2001]
  • Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation
    Minet E Free Radic Biol Med 31 847-855 [2001]
  • The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization
    Kanavi MR Molecules 19 : 17578 ~ 17603 [2014]
  • The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization
    Kanavi MR Molecules 19 17578-17603 [2014]
  • The mouse retina as an angiogenesis model
    Stahl A Invest Ophthalmol Vis Sci 51 : 2813 ~ 2826 [2010]
  • The mouse retina as an angiogenesis model
    Stahl A Invest Ophthalmol Vis Sci 51 2813-2826 [2010]
  • Targeting HIF-1 for cancer therapy
    Semenza GL Nat Rev Cancer 3 : 721 ~ 732 [2003]
  • Targeting HIF-1 for cancer therapy
    Semenza GL Nat Rev Cancer 3 721-732 [2003]
  • Signal transduction to hypoxia-inducible factor 1
    Semenza G. Biochem Pharmacol 64 : 993 ~ 998 [2002]
  • Signal transduction to hypoxia-inducible factor 1
    Semenza G. Biochem Pharmacol 64 993-998 [2002]
  • Senile macular degeneration: a case-control study
    Hyman LG Am J Epidemiol 118 : 213 ~ 227 [1983]
  • Senile macular degeneration: a case-control study
    Hyman LG Am J Epidemiol 118 213-227 [1983]
  • Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study
    Massin P Diabetes Care 33 : 2399 ~ 2405 [2010]
  • Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study
    Massin P Diabetes Care 33 2399-2405 [2010]
  • Resveratrol: a multifunctional cytoprotective molecule
    Juhasz B Curr Pharm Biotechnol 11 : 810 ~ 818 [2010]
  • Resveratrol: a multifunctional cytoprotective molecule
    Juhasz B Curr Pharm Biotechnol 11 810-818 [2010]
  • Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway
    Khan AA Am J Pathol 177 : 481 ~ 492 [2010]
  • Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway
    Khan AA Am J Pathol 177 481-492 [2010]
  • Resveratrol inhibits proliferation of hypoxic choroidal vascular endothelial cells
    Balaiya S Mol Vis 19 : 2385 ~ 2392 [2013]
  • Resveratrol inhibits proliferation of hypoxic choroidal vascular endothelial cells
    Balaiya S Mol Vis 19 2385-2392 [2013]
  • Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-)mice
    Hua J Invest Ophthalmol Vis Sci 52 : 2809 ~ 2816 [2011]
  • Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-)mice
    Hua J Invest Ophthalmol Vis Sci 52 2809-2816 [2011]
  • Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells
    Zhang Q Mol Cancer Ther 4 : 1465 ~ 1474 [2005]
  • Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells
    Zhang Q Mol Cancer Ther 4 1465-1474 [2005]
  • Resveratrol improves health and survival of mice on a high-calorie diet
    Baur JA Nature 444 : 337 ~ 342 [2006]
  • Resveratrol improves health and survival of mice on a high-calorie diet
    Baur JA Nature 444 337-342 [2006]
  • Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor
    Kaga S J Mol Cell Cardiol 39 : 813 ~ 822 [2005]
  • Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor
    Kaga S J Mol Cell Cardiol 39 813-822 [2005]
  • Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells
    Jiang H J Exp Ther Oncol 8 : 25 ~ 33 [2009]
  • Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells
    Jiang H J Exp Ther Oncol 8 25-33 [2009]
  • Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas
    Kim YH Acta Ophthalmol 90 : e31 ~ e37 [2012]
  • Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas
    Kim YH Acta Ophthalmol 90 e31-e37 [2012]
  • Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway
    Huang LE Proc Natl Acad Sci U S A 95 : 7987 ~ 7992 [1998]
  • Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway
    Huang LE Proc Natl Acad Sci U S A 95 7987-7992 [1998]
  • Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    Brown DM N Engl J Med 355 : 1432 ~ 1444 [2006]
  • Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    Brown DM N Engl J Med 355 1432-1444 [2006]
  • Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions
    Lux A Br J Ophthalmol 91 : 1318 ~ 1322 [2007]
  • Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions
    Lux A Br J Ophthalmol 91 1318-1322 [2007]
  • Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib
    Br J Ophthalmol 93 : 958 ~ 963 [2009]
  • Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib
    Chung EJ Br J Ophthalmol 93 958-963 [2009]
  • Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol
    Park SY Cancer Lett 258 : 63 ~ 69 [2007]
  • Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol
    Park SY Cancer Lett 258 63-69 [2007]
  • HIF-1: mediator of physiological and pathophysiological responses to hypoxia
    Semenza GL J Appl Physiol 88 : 1474 ~ 1480 [2000]
  • HIF-1: mediator of physiological and pathophysiological responses to hypoxia
    Semenza GL J Appl Physiol 88 1474-1480 [2000]
  • Expression of hypoxia-inducible factor-1alpha and -2alpha in human choroidal neovascular membranes
    Sheridan CM Graefes Arch Clin Exp Ophthalmol 247 : 1361 ~ 1367 [2009]
  • Expression of hypoxia-inducible factor-1alpha and -2alpha in human choroidal neovascular membranes
    Sheridan CM Graefes Arch Clin Exp Ophthalmol 247 1361-1367 [2009]
  • Expression of hypoxia-inducible factor 1alpha and 2alpha in choroidal neovascular membranes associated with age-related macular degeneration
    Inoue Y Br J Ophthalmol 91 : 1720 ~ 1721 [2007]
  • Expression of hypoxia-inducible factor 1alpha and 2alpha in choroidal neovascular membranes associated with age-related macular degeneration
    Inoue Y Br J Ophthalmol 91 1720-1721 [2007]
  • Expression of hypoxia-inducible factor 1: mechanisms and consequences
    Semenza GL Biochem Pharmacol 59 : 47 ~ 53 [2000]
  • Expression of hypoxia-inducible factor 1: mechanisms and consequences
    Semenza GL Biochem Pharmacol 59 47-53 [2000]
  • Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity
    Mintz-Hittner HA N Engl J Med 364 : 603 ~ 615 [2011]
  • Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity
    Mintz-Hittner HA N Engl J Med 364 603-615 [2011]
  • Effect of cediranib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, in a mouse model of choroidal neovascularization
    Kang S Clin Experiment Ophthalmol 41 : 63 ~ 72 [2013]
  • Effect of cediranib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, in a mouse model of choroidal neovascularization
    Kang S Clin Experiment Ophthalmol 41 63-72 [2013]
  • Cancer chemopreventive activity of resveratrol, a natural productderived from grapes
    Jang M Science 275 : 218 ~ 220 [1997]
  • Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
    Jang M Science 275 218-220 [1997]
  • Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice
    Kang S Exp Eye Res 112 : 125 ~ 133 [2013]
  • Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice
    Kang S Exp Eye Res 112 125-133 [2013]